WORLD PHARMACEUTICAL MARKET: TRENDWATCHING-Reference-Cited by-同舟云学术

WORLD PHARMACEUTICAL MARKET: TRENDWATCHING

Published:2022 Issue:3 Volume: Page:56-68
ISSN:2712-9330
Container-title:Laboratornaya i klinicheskaya meditsina. Farmatsiya
language:
Short-container-title:

Author:

Dremova N. B.,Solomka S. V.

Abstract

At present, the importance of the pharmaceutical sector of the economy has increased significantly in public perception. This review provides up-to-date information at the beginning of 2022 on the main trends in the global pharmaceutical market. Among the current trends are: the key role of pharmaceuticals in the fight against the SARS-Covid-19 pandemic, the problems of a latent pandemic of drug-resistant infections, the high cost of new drugs and an increase in the market share of cheap biosimilars, the expansion of cooperation between developers of new drugs and vaccines, features in changes in the structure pharmaceutical companies, expanding opportunities in the retail pharmaceutical market, analysts՚ opinions on market prospects for the next 5 years. Materials from open sources were used: industry and business media, websites of pharmaceutical companies and non-profit organizations, WHO publications and scientific publications.

Publisher

Izdatel'skii dom Spektr, LLC

Reference27 articles.

1. Ponomareva EV. TRENDWATCHING. Kak nayti idei dlya sozdaniya i razvitiya biznesa. Moscow: Litres; 2021. (In Russ). ISBN 9785042232121. Available at: https://www.litres.ru/elena-vasilevna-pono/trendwatching-kak-nayti-idei-dlya-sozdaniya-i-razviti/ (Accessed: 10 Feb 2022).

2. COVAX Announces new agreement, plans for first deliveries: News release. Geneva: WHO. 22 Jan 2021. Available at: https://www.who.int/news/item/22-01-2021-covax-announces-new-agreement-plans-for-first-deliveries (Accessed: 10 Sep 2021).

3. Evaluate Pharma World Preview 2021. Outlook to 2026 report. 14th ed. London: Evaluate Ltd., 2021. Available at: https://www.evaluate.com/thought-leadership/pharma/evaluate-pharma-world-preview-2021-outlook-2026 (Accessed: 10 Sep 2021).

4. Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for Molnupiravir, an Investigational Oral Antiviral Medi-cine, for the Treatment of COVID-19 in Adults: News release by Merck. 25 Oct 2021. Available at: https://www.merck.com/news/merck-and-ridgeback-announce-initiation-of-a-rolling-review-by-the-european-medicines-agency-for-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-covid-19-in-adults/ (Accessed: 25 Oct 2021).

5. Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treat-ment: Press Release Pfizer. 22 Dec 2021. Available at: https://investors.pfizer.com/Investors/News/news-details/ 2021/Pfizer-Receives-U.S.-FDA-Emergency-Use-Authori-zation-for-Novel-COVID-19-Oral-Antiviral-Treatment/default.aspx (Accessed: 25 Dec 2021).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilar of analogue of insulin glargin: proven safety, effectiveness, interchangeability;Meditsinskiy sovet = Medical Council;2023-01-20

2. Russian-Hungarian cooperation in the pharmaceutical sector and the impact of anti-russian sanctions;International Trade and Trade Policy;2023-01-15